Edarbi
These HIGHLIGHTS do not include all the information needed to use EDARBI safely and effectively. See full prescribing information for EDARBI. Edarbi (azilsartan medoxomil) tablets, for oral use Initial U.S. Approval: 2011
52b27c75-9f5a-4816-bafd-dace9d7d2063
HUMAN PRESCRIPTION DRUG LABEL
Jan 23, 2024
Azurity Pharmaceuticals, Inc.
DUNS: 117505635
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Azilsartan kamedoxomil
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (8)
Azilsartan kamedoxomil
Product Details
FDA regulatory identification and product classification information